Letter: Ozanimod and Vedolizumab as First-Line Advanced Therapies in Ulcerative Colitis: Authors' Reply
PMID: 39729488
Source: Inflamm Bowel Dis
Publication date:
2025-07-24
Year:
2025
Abstract
NULL